Ethyl Pyruvate Reduces Acute Lung Injury Via Regulation of iNOS and HO-1 Expression in Endotoxemic Rats

Published:February 03, 2011DOI:


      Ethyl pyruvate (EP) has been shown to attenuate lipopolysaccharide (LPS)-induced acute lung injury (ALI). Induction of heme oxygenase-1 (HO-1) and suppression of inducible nitric oxide synthase (iNOS) expression provide cytoprotection in lung and vascular injury. The aim of this study is to evaluate whether the beneficial effect of EP on lung inflammation is related to HO-1 induction in a rat model of LPS-induced ALI.

      Materials and Methods

      Rats were administered LPS (30 mg/kg) by intravenous infusion for 4 h to induce ALI. EP (20, 40, and 60 mg/kg/4 h i.v. infusion) or vehicle was given 1 h after LPS initiation.


      EP 40 and 60 mg/kg attenuated plasma levels of TNF-α and IL-6 caused by LPS, and further increased IL-10 levels compared with the LPS group. At 6 h after LPS initiation, iNOS protein expression in lungs and plasma NO metabolite levels were markedly increased, which were reduced by EP 60 mg/kg. LPS caused a significant HO-1 induction, whereas administration of EP 60 mg/kg significantly induced higher HO-1 expression compared with the LPS group. The beneficial effects of EP on cytokines and iNOS expression were reversed by HO-1 inhibitor SnPP. EP significantly suppressed phosphorylated p38 MAPK and increased phosphorylated ERK1/2 protein levels in the lung tissue. The edema and infiltration of neutrophils into lungs was reduced by EP.


      EP reduced LPS-induced ALI, which may be mediated by induction of HO-1. The underlying mechanisms are associated with suppression of p38 MAPK and increase of ERK1/2 signaling pathway activation.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Flierl M.A.
        • Rittirsch D.
        • Hoesel L.M.
        • et al.
        Acute lung injury: A challenging transfer from bench to bedside.
        Med Hypothesis Res. 2006; 3: 727
        • Kabir K.
        • Gelinas J.P.
        • Chen M.
        • et al.
        Characterization of a murine model of endotoxin-induced acute lung injury.
        Shock. 2002; 17: 300
        • Kim J.Y.
        • Park J.S.
        • Strassheim D.
        • et al.
        HMGB1 contributes to the development of acute lung injury after hemorrhage.
        Am J Physiol Lung Cell Mol Physiol. 2005; 288: L958
        • Kilbourn R.
        The discovery of nitric oxide as a key mediator in septic shock.
        Sepsis. 1998; 1: 85
        • Numata M.
        • Suzuko S.
        • Miyazawa N.
        • et al.
        Inhibition of iNOS prevents LPS-induced acute lung injury in dogs.
        J Immunol. 1998; 160: 3031
        • Triilieff A.
        • Fujitan Y.
        • Mentz F.
        • et al.
        Inducible nitric oxide synthase inhibitors suppresses airway inflammation in mice through down-regulation of chemokine expression.
        J Immunol. 2000; 165: 1526
        • Razavi H.M.
        • Wang F.
        • Weicker S.
        • et al.
        Pulmonary neutrophil infiltration in murine sepsis: Role of inducible nitric oxide synthase.
        Am J Respir Crit Care Med. 2004; 170: 227
        • Dugo L.
        • Marzocco S.
        • Mazzon E.
        • et al.
        Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation.
        Br J Pharmacol. 2004; 141: 979
        • McCluskie K.
        • Birrell M.A.
        • Wong S.
        • et al.
        Nitric oxide as a noninvasive biomarker of lipopolysaccharide-induced airway inflammation: Possible role in lung neutrophilia.
        J Pharmacol Exp Ther. 2004; 311: 625
        • Hartsfield C.L.
        Crosstalk between carbon monoxide and nitric oxide.
        Antioxid Redox Signal. 2002; 4: 301
        • Katori M.
        • Busuttil R.W.
        • Kupiec-Weglinski J.W.
        Heme oxygenase-1 system in organ transplantation.
        Transplantation. 2002; 74: 905
        • Bauer M.
        • Huse K.
        • Settmacher U.
        • et al.
        The heme oxygenase-carbon monoxide system: Regulation and role in stress response and organ failure.
        Intensive Care Med. 2008; 34: 640
        • Wiesel P.
        • Patel A.P.
        • DiFonzo N.
        • et al.
        Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice.
        Circulation. 2000; 102: 3015
        • Sarady J.K.
        • Otterbein S.L.
        • Liu F.
        • et al.
        Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages.
        Am J Respir Cell Mol Biol. 2002; 27: 739
        • Wang W.W.
        • Smith D.L.
        • Zucker S.D.
        Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats.
        Hepatology. 2004; 40: 424
        • Ulloa L.
        • Ochani M.
        • Yang H.
        • et al.
        Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.
        Proc Natl Acad Sci USA. 2002; 99: 12351
        • van Zoelen M.A.
        • de Vos A.F.
        • Larosa G.J.
        • et al.
        Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide- and lipoteichoic acid-induced lung inflammation in vivo.
        Shock. 2007; 28: 570
        • Shang G.H.
        • Lin D.J.
        • Xiao W.
        • et al.
        Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model.
        Respir Res. 2009; 10: 91
        • Yang R.
        • Gallo D.J.
        • Baust J.J.
        • et al.
        Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock.
        Am J Physiol Gastrointest Liver Physiol. 2002; 283: G212
        • Uchiyama T.
        • Delude R.L.
        • Fink M.P.
        Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion.
        Intensive Care Med. 2003; 29: 2050
        • Song M.
        • Kellum J.A.
        • Kaldas H.
        • et al.
        Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured LPS-stimulated RAW 264.7 cells.
        J Pharmacol Exp Ther. 2004; 308: 307
        • Varma S.D.
        • Devamanoharan P.S.
        • Ali A.H.
        Prevention of intracellular oxidative stress to lens by pyruvate and its ester.
        Free Rad Res. 1998; 28: 131
        • Lee Y.M.
        • Cheng P.Y.
        • Hong S.F.
        • et al.
        Oxidative stress induces vascular heme oxygenase-1 expression in ovariectomized rats.
        Free Rad Biol Med. 2005; 39: 108
        • Su C.F.
        • Yang F.L.
        • Chen H.I.
        Inhibition of inducible nitric oxide synthase attenuates acute endotoxin-induced lung injury in rats.
        Clin Exp Pharmacol Physiol. 2007; 34: 339
        • van Zoeleny M.A.
        • Bakhtiari K.
        • Dessing M.C.
        • et al.
        Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells.
        Thromb Haemost. 2006; 96: 789
        • Venkataraman R.
        • Kellum J.A.
        • Song M.
        • et al.
        Resuscitation with Ringer’s ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock.
        Shock. 2002; 18: 507
        • Van der Poll T.
        • van Deventer S.J.
        Cytokines and anticytokines in the pathogenesis of sepsis.
        Infect Dis Clin North Am. 1999; 13: 413
        • Oberholzer A.
        • Oberholzer C.
        • Moldawer L.L.
        • et al.
        The therapeutic potential of interleukin-10 in infection and inflammation.
        Arch Immunol Ther Exp. 2000; 48: 529
        • Latifi S.Q.
        • O’Riordan M.A.
        • Levine A.D.
        Interleukin-10 controls the onset of irreversible septic shock.
        Infect Immun. 2002; 70: 4441
        • Romani L.
        • Puccetti P.
        • Mencacci A.
        • et al.
        Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans.
        J Immunol. 1994; 152: 3514
        • Lee T.S.
        • Chau L.Y.
        Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice.
        Nat Med. 2002; 8: 240
        • Takaki S.
        • Takeyama N.
        • Kajita Y.
        • et al.
        Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock.
        Intensive Care Med. 2010; 36: 42
        • Scott J.R.
        • Chin B.Y.
        • Bilban M.H.
        • et al.
        Restoring homeostasis: Is heme oxygenase-1 ready for the clinic?.
        Trends Pharmacol Sci. 2007; 28: 200
        • Sawle P.
        • Foresti R.
        • Mann B.E.
        • et al.
        Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
        Br J Pharmacol. 2005; 145: 800
        • Otterbein L.E.
        • Bach F.H.
        • Alam J.
        • et al.
        Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway.
        Nat Med. 2000; 4: 422
        • Gong Q.
        • Yin H.
        • Fang M.
        • et al.
        Heme oxygenase-1 up-regulation significantly inhibits TNF-α and HMGB1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice.
        Int Immunopharmacol. 2008; 8: 792
        • Kapturczak M.H.
        • Wasserfall C.
        • Brusko T.
        • et al.
        Heme oxygenase-1 modulates early inflammatory responses: Evidence from the heme oxygenase-1-deficient mouse.
        Am J Pathol. 2004; 165: 1045
        • Dave S.H.
        • Tilstra J.S.
        • Matsuoka K.
        • et al.
        Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.
        J Leukoc Biol. 2009; 86: 633
        • Motterlini R.
        • Mann B.E.
        • Foresti R.
        Therapeutic applications of carbon monoxide releasing molecules.
        Expert Opin Investig Drugs. 2005; 14: 1305
        • Immenschuh S.
        • Ramadori G.
        Gene regulation of heme oxygenase-1 as a therapeutic target.
        Biochem Pharmacol. 2000; 60: 1121
        • Saccani S.
        • Pantano S.
        • Natoli G.
        p38-dependent marking of inflammatory genes for increased NF-kB recruitment.
        Nat Immunol. 2002; 3: 69
        • Porras A.
        • Zuluaga S.
        • Black E.
        • et al.
        p38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli.
        Mol Biol Cell. 2004; 15: 922
        • Silva G.
        • Cunha A.
        • Gregoire I.P.
        • et al.
        The anti-apoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 α MAPK isoform.
        J Immunol. 2006; 177: 1894
        • Sims C.A.
        • Wattanasirichaigoon S.
        • Menconi M.J.
        • et al.
        Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats.
        Crit Care Med. 2001; 29: 1513